You are here » Home » Companies » Company Overview » Aarti Drugs Ltd

Aarti Drugs Ltd.

BSE: 524348 Sector: Health care
NSE: AARTIDRUGS ISIN Code: INE767A01016
BSE LIVE 13:56 | 06 Dec 641.15 -7.25
(-1.12%)
OPEN

644.05

HIGH

650.40

LOW

640.00

NSE LIVE 13:56 | 06 Dec 645.90 -1.05
(-0.16%)
OPEN

652.00

HIGH

653.65

LOW

621.10

OPEN 644.05
PREVIOUS CLOSE 648.40
VOLUME 727
52-Week high 684.00
52-Week low 431.10
P/E 20.00
Mkt Cap.(Rs cr) 1552.87
Buy Price 642.65
Buy Qty 10.00
Sell Price 645.55
Sell Qty 5.00
OPEN 644.05
CLOSE 648.40
VOLUME 727
52-Week high 684.00
52-Week low 431.10
P/E 20.00
Mkt Cap.(Rs cr) 1552.87
Buy Price 642.65
Buy Qty 10.00
Sell Price 645.55
Sell Qty 5.00

Aarti Drugs Ltd. (AARTIDRUGS) - Company Information

Aarti Drugs Ltd

Aarti Drugs Ltd is one of the leading pharmaceutical manufacturers in India. The company is engaged manufacturing of pharmaceuticals. ADL operates in the anti-diarrhea, anti-inflammatory and anti-biotic therapeutic segments. They manufacture vitamins, anti-arthritis, anti-fungal, antibiotics, antibiotics and angiotensin converting enzyme (ACE) inhibitors in their manufacturing units located at Tar...> More

COMPANY INFORMATION
Chairman Emeritus : Chandrakant V Gogri
Chairman and MD & CEO : Prakash M Patil
Joint Managing Director : Harshit M Savla
Whole-time Director : Harit P Shah
Whole-time Director : Uday M Patil
Independent Director : Ramdas M Gandhi
Independent Director : Bhavesh R Vora
Independent Director : Krishnacharya G Akamanchi
Independent Director : Vilas G Gaikar
Independent Director : Navin C Shah
Managing Director : Rashesh C Gogri
Independent Director : Priti P Savla
Company Secretary : Vibhav S Ranade
Director : Rajendra V Gogri
AUDITOR : Gokhale & Sathe
IND NAME : Pharmaceuticals - Indian - Bulk Drugs
HOUSE NAME : Alchemie Group
Registered office
Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal,Thane,Maharashtra-401506
Ph : 91-22-24072249
WEBSITE : http://www.aartidrugs.com
E-mail : investorrelations@aartidrugs.com

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard